MCID: NNT006
MIFTS: 27

Neonatal Myasthenia Gravis malady

Categories: Immune diseases, Neuronal diseases, Fetal diseases, Bone diseases, Rare diseases

Aliases & Classifications for Neonatal Myasthenia Gravis

About this section

Aliases & Descriptions for Neonatal Myasthenia Gravis:

Name: Neonatal Myasthenia Gravis 10 12
 
Myasthenia Gravis, Neonatal 36

Classifications:



External Ids:

Disease Ontology10 DOID:14043
ICD9CM29 775.2
SNOMED-CT59 82178003
MeSH36 D020941
UMLS65 C0158982

Summaries for Neonatal Myasthenia Gravis

About this section
MalaCards based summary: Neonatal Myasthenia Gravis, also known as myasthenia gravis, neonatal, is related to transient neonatal myasthenia gravis and myasthenia gravis. An important gene associated with Neonatal Myasthenia Gravis is CHRNG (Cholinergic Receptor Nicotinic Gamma Subunit). Affiliated tissues include prostate, lung and testes, and related mouse phenotypes are respiratory system and mortality/aging.

Related Diseases for Neonatal Myasthenia Gravis

About this section

Graphical network of diseases related to Neonatal Myasthenia Gravis:



Diseases related to neonatal myasthenia gravis

Symptoms for Neonatal Myasthenia Gravis

About this section

Drugs & Therapeutics for Neonatal Myasthenia Gravis

About this section

Drugs for Neonatal Myasthenia Gravis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Cyclophosphamideapproved, investigationalPhase 1264350-18-0, 6055-19-22907
Synonyms:
(+-)-Cyclophosphamide
(-)-Cyclophosphamide
(RS)-Cyclophosphamide
1-(bis(2-chloroethyl)amino)-1-oxo-2-aza-5-oxaphosphoridine
1-Bis(2-chloroethyl)amino-1-oxo-2-aza-5-oxaphosphoridin
2-[Bis(2-chloroethylamino)]-tetrahydro-2H-1,3,2-oxazaphosphorine-2-oxide
4-Hydroxy-cyclophosphan-mamophosphatide
50-18-0
60007-95-6
6055-19-2 (monohydrate)
75526-90-8
AC1L1EQQ
AI3-26198
ASTA
ASTA B518
Asta B 518
B 518
B-518
BRN 0011744
BSPBio_002099
Bis(2-chloroethyl)phosphoramide cyclic propanolamide ester
C 0768
C07888
C7H15Cl2N2O2P
CB 4564
CB-4564
CCRIS 188
CHEBI:4027
CHEMBL32520
CHEMBL88
CID2907
CP
CPA
CTX
CY
Ciclofosfamida
Ciclofosfamida [INN-Spanish]
Ciclofosfamide
Ciclophosphamide
Ciclophosphamide [INN]
Clafen
Claphene
Cycloblastin
Cyclophosphamid
Cyclophosphamide
Cyclophosphamide (INN)
Cyclophosphamide (TN)
Cyclophosphamide (anhydrous form)
Cyclophosphamide (anhydrous)
Cyclophosphamide Monohydrate
Cyclophosphamide Sterile
Cyclophosphamide anhydrous
Cyclophosphamide, (+-)-Isomer
Cyclophosphamides
Cyclophosphamidum
Cyclophosphamidum [INN-Latin]
Cyclophosphan
Cyclophosphane
Cyclophosphanum
Cyclophosphoramide
Cyclostin
Cyklofosfamid
Cyklofosfamid [Czech]
Cytophosphan
Cytophosphane
Cytoxan
Cytoxan (TN)
Cytoxan Lyoph
D,L-Cyclophosphamide
D07760
DB00531
 
DivK1c_000246
EINECS 200-015-4
EU-0100238
Endoxan
Endoxan R
Endoxan-Asta
Endoxana
Endoxanal
Endoxane
Enduxan
Genoxal
HMS2090A12
HSDB 3047
Hexadrin
IDI1_000246
KBio1_000246
KBio2_001338
KBio2_003906
KBio2_006474
KBio3_001319
KBioGR_000888
KBioSS_001338
LS-1302
LS-99787
Ledoxina
Lopac-C-0768
Lopac0_000238
Lyophilized Cytoxan
Mitoxan
MolPort-001-783-420
N,N-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,N-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
NCGC00015209-01
NCGC00015209-03
NCGC00015209-06
NCGC00091741-02
NCGC00091741-03
NCI-C04900
NCI60_002097
NINDS_000246
NSC 26271
NSC-26271
NSC26271
NSC273033
NSC273034
Neosar
Occupation, cyclophosphamide exposure
Procytox
RCRA waste no. U058
Rcra Waste Number U058
Rcra waste number U058
Revimmune
S1217_Selleck
SK 20501
SPBio_001071
STK177249
STOCK2S-91217
Semdoxan
Sendoxan
Senduxan
Spectrum2_001146
Spectrum3_000370
Spectrum4_000304
Spectrum5_000795
Spectrum_000858
UNII-6UXW23996M
WLN: T6MPOTJ BO BN2G2G
Zyklophosphamid
Zyklophosphamid [German]
bis(2-Chloroethyl)phosphami de cyclic propanolamide
bis(2-Chloroethyl)phosphamide cyclic propanolamide ester
cyclophosphamide

Interventional clinical trials:

idNameStatusNCT IDPhase
1Hematopoietic Stem Cell Therapy for Patients With Refractory Myasthenia GravisActive, not recruitingNCT00424489Phase 1

Search NIH Clinical Center for Neonatal Myasthenia Gravis


Cochrane evidence based reviews: myasthenia gravis, neonatal

Genetic Tests for Neonatal Myasthenia Gravis

About this section

Anatomical Context for Neonatal Myasthenia Gravis

About this section

MalaCards organs/tissues related to Neonatal Myasthenia Gravis:

33
Prostate, Lung, Testes, Breast, Endothelial, T cells, Myeloid

Animal Models for Neonatal Myasthenia Gravis or affiliated genes

About this section

MGI Mouse Phenotypes related to Neonatal Myasthenia Gravis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053888.7AQP4, CHRNG, MB, MUSK
2MP:00107687.0AFP, AQP4, CHRNG, DPAGT1, MB, MUSK

Publications for Neonatal Myasthenia Gravis

About this section

Articles related to Neonatal Myasthenia Gravis:

(show all 45)
idTitleAuthorsYear
1
50 Years Ago in TheJournal ofPediatrics: Neonatal Myasthenia Gravis. (27017463)
2016
2
Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis. (26989568)
2016
3
Prenatal immunomodulation treatment in neonatal myasthenia gravis. (23982940)
2013
4
Transient neonatal myasthenia gravis revealing a myasthenia gravis and a systemic lupus erythematosus in the mother: case report and review of the literature. (19488958)
2010
5
Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis. (19955986)
2009
6
Can neonatal myasthenia gravis be predicted? (18681836)
2008
7
Isolated facial and bulbar paresis: a persistent manifestation of neonatal myasthenia gravis. (18195270)
2008
8
Seronegative neonatal myasthenia gravis in one of the twins. (15475637)
2004
9
Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis. (9931536)
1999
10
Intravenous immunoglobulin in neonatal myasthenia gravis. (10586190)
1999
11
High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis. (9535308)
1998
12
Transient neonatal myasthenia gravis and pyloric stenosis. (8534471)
1995
13
Neonatal myasthenia gravis and the role of agalactosyl IgG. (8679902)
1995
14
Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor. (8040310)
1994
15
The role of intrapartum vibroacoustic stimulation in the prediction of neonatal myasthenia gravis. (8022331)
1994
16
Transient neonatal myasthenia gravis. (1573230)
1992
17
Presence of anti-acetylcholine receptor antibodies in human milk: possible correlation with neonatal myasthenia gravis. (1391599)
1992
18
Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance. (1883479)
1991
19
Neonatal myasthenia gravis: antigenic specificities of antibodies in sera from mothers and their infants. (1695559)
1990
20
Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity. (2908881)
1989
21
Neonatal myasthenia gravis: specific advantages of repetitive stimulation over edrophonium testing. (3242526)
1988
22
Neonatal myasthenia gravis: a new clinical and immunologic appraisal on 30 cases. (3336445)
1988
23
Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants. (3734055)
1986
24
Neonatal myasthenia gravis. Anti-acetylcholine receptor antibodies in the amniotic fluid. (6746895)
1984
25
Neonatal myasthenia gravis in the infant of an asymptomatic thymectomized mother. (7104893)
1982
26
Antiacetylcholine receptor antibody in neonatal myasthenia gravis. (6163352)
1981
27
Exchange transfusion in neonatal myasthenia gravis. (7195520)
1981
28
Neonatal myasthenia gravis. (7211772)
1981
29
Acetylcholine receptor antibodies in absence of neonatal myasthenia gravis. (7436824)
1980
30
Respiratory studies in an infant with neonatal myasthenia gravis. (464928)
1979
31
Neonatal myasthenia gravis in the infant of a myasthenic mother in remission. (574370)
1979
32
Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor. (92675)
1979
33
Prolonged neonatal myasthenia gravis: electrophysiological studies. (727721)
1978
34
The role of anti-acetylcholine receptor antibody in neonatal myasthenia gravis. (757366)
1978
35
Nursing care study: transient neonatal myasthenia gravis. (250054)
1978
36
Anti-acetylcholine receptor IgG in neonatal myasthenia gravis. (865592)
1977
37
Time course of neonatal myasthenia gravis and unsuspectedly long duration of neuromuscular block in distal muscles. (190536)
1977
38
Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. (830279)
1977
39
Monitoring muscle weakness in neonatal myasthenia gravis. (1203704)
1975
40
Letter: Neonatal myasthenia gravis. (4448549)
1974
41
Neonatal myasthenia gravis and antimuscle antibodies. (4926622)
1971
42
Neonatal myasthenia gravis: report of two cases and review of the literature. (5309787)
1970
43
Neonatal myasthenia gravis. (4179873)
1969
44
Pregnancy in myasthenia gravis and neonatal myasthenia gravis. (13268469)
1955
45
Neonatal myasthenia gravis; report of a case. (13009187)
1953

Variations for Neonatal Myasthenia Gravis

About this section

Expression for genes affiliated with Neonatal Myasthenia Gravis

About this section
Search GEO for disease gene expression data for Neonatal Myasthenia Gravis.

Pathways for genes affiliated with Neonatal Myasthenia Gravis

About this section

GO Terms for genes affiliated with Neonatal Myasthenia Gravis

About this section

Sources for Neonatal Myasthenia Gravis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet